Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
W., Luger T
It is one of the most studied next-generation GLP-1 class molecules in current clinical research (under the trade name LY3437943 in active Eli Lilly trials)
Meanwhile, other classes such as insulins and dipeptidyl peptidase-4 (DPP4) inhibitors are rarely used as first-line therapies today, instead serving as follow-on options when additional control is needed
Data from market tracker PharmaTrac showed in terms of sales volume, semaglutide's market share has jumped in the last two months to 21% from 13%, after the company announced a steep price cut for Wegovy in November, followed by the launch of Ozempic in December at a much lower price point than Lilly's drug
This creates a tug-of-war between two powerful metabolic forces
that Americans cannot get enough of them literally
